Total Funding
75
84
Total FundingPre-Seed raised
Growth Score 75 in past quarter
27 pts
Heat Score 84 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
49643
Endometriosis develops genomic biomarker designed to be used for the early detection of endometriosis.
- Dr. Yana Aznavour: CEO & Founder
About the Company
Endometrics is a creator of a genetic biomarker for the early identification of endometriosis. The biomarker developed by the company is a condition in which tissue normally found inside the uterine lining grows outside of the uterus in places such as the ovaries, fallopian tubes, bowel, and bladder and aids in the transformation of molecular data
into a novel diagnostic, allowing women to overcome chronic pain associated with endometriosis.
Women Founded